Body — 8 lenses: [Science: alpha-2 agonists (xylazine, medetomidine — veterinary sedatives), nitazenes as μ-opioid agonists (synthesized in 1950s, never approved, re-emerging), kratom mitragynine partial μ-agonist + alpha-2, tianeptine atypical antidepressant with opioid activity at high doses. Biology: xylazine causes necrotic skin ulcers characteristic + prolonged sedation not reversed by naloxone; nitazenes act like high-potency fentanyl analogs (naloxone-reversible, higher dosing may be needed); kratom has its own withdrawal syndrome; tianeptine “gas station heroin” causing emergency-dept surges. Psychology: dependence patterns mirror the parent class but often with gaps in clinical recognition. Policy: DEA scheduling scramble — xylazine FDA-declared emerging threat, nitazene analogs being scheduled piecemeal, kratom DEA deferred twice, tianeptine state-by-state patchwork. Trends: xylazine now in 48 states’ supply; medetomidine identified in Chicago-area 2024; kratom retail boom. Social: the “legal high” marketing arms race; the gap between policy and supply. Treatment: xylazine wound care + opioid co-treatment; nitazene overdose reversal with naloxone; kratom dependence — buprenorphine effective; tianeptine dependence — like opioids. Harm reduction: test strips for xylazine + nitazenes (where available), stay with person during prolonged sedation, don’t use alone, high-dose naloxone availability.]
How these pillars plug into the system
Each substance pillar post is created with post_type: pillar and its newsroom_substance_categories.pillar_post_id is set to its ID. The 8 lens section summaries (2–3 sentences each) are additionally copied into the lens_*_summary columns on the substance_categories row — so the public substance pillar page (/newsroom/substances/[class]) can render the 8-lens skeleton even before the daily task has begun filling lens-specific cluster posts.
Specific-substance pillars (for fentanyl, alcohol, meth, cannabis, psilocybin, ketamine, kratom, xylazine, nitazenes, etc.) become the next tier of evergreen work. The daily task will nominate 1–2 substance-specific pillars per week based on the substance-coverage endpoint’s neglected list. Nick/Pat/Chris approve, they get published, and the coverage matrix fills in.
Updated publishing cadence (with substance pillars added)
Day 0: Publish SP-01 through SP-08 (thematic pillars) — 8 posts Day 1: Publish SP-19 through SP-21 (opioids, stimulants, alcohol) — 3 substance pillars (highest-volume) Day 2: Publish SP-22 + SP-23 (depressants, cannabinoids) Day 3: Publish SP-24 + SP-25 (dissociatives, psychedelics) Day 4: Publish SP-26 + SP-27 + SP-28 (nicotine, inhalants, NPS) Day 5–10: SP-09 through SP-18 (thematic cluster posts from original seed list) + daily task output
By end of week two: 28 seed posts + ~14 daily posts = ~42 interlinked, cross-dimensional pieces — a newsroom that reads comprehensive on day one.
Sources Cited
- 01.Ahttps://www.dea.gov/resources/intelligenceDEA Intelligence
- 02.Ahttps://www.cdc.gov/mmwr/CDC MMWR
Filed Under
sciencebiologypsychologypolicytrendssocial-culturaltreatmentharm-reductionPeer-Reviewed Research